A large number of studies in the last two decades suggest that central insulin resistance and cognitive decline in AD are associated with changes in the neuronal insulin/IR signal transduction cascade, insulin grow factor 1 (IGF-1) resistance and insulin receptor substrate 1 (IRS-1) dysregulation [35,36]. The gene discussed is IRS1; the disease is Alzheimer disease.